Edwin A. Basak
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Biosimilars and Bioanalytical Methods
- T-cell and B-cell Immunology
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 15
-
- Biosimilars and Bioanalytical Methods 1
- Co-authors
- Stijn L.W. Koolen (13 shared papers)Ron H.J. Mathijssen (14 shared papers)Joachim G.J.V. Aerts (12 shared papers)Astrid Aplonia Maria van der Veldt (12 shared papers)Sander Bins (12 shared papers)Reno Debets (11 shared papers)Esther Oomen‐de Hoop (9 shared papers)Daan P. Hurkmans (8 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (5 papers)Annals of Oncology (3 papers)European Journal of Cancer (2 papers)Thyroid (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- NetherlandsSwitzerland
In The Last Decade
Edwin A. Basak
15 papers receiving 450 citations
Peers
Comparison fields: 5 of 42
- Oncology 339
- Immunology 42
- Pulmonary and Respiratory Medicine 41
- Pharmacology 12
- Endocrinology, Diabetes and Metabolism 17
Countries citing papers authored by Edwin A. Basak
This map shows the geographic impact of Edwin A. Basak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin A. Basak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin A. Basak more than expected).
Fields of papers citing papers by Edwin A. Basak
This network shows the impact of papers produced by Edwin A. Basak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin A. Basak. The network helps show where Edwin A. Basak may publish in the future.
Co-authors
The 25 scholars most cited alongside Edwin A. Basak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 76 | |
| 2 | 2020 | 73 | |
| 3 | 2019 | 61 | |
| 4 | 2018 | 60 | |
| 5 | 2020 | 56 | |
| 6 | 2019 | 50 | |
| 7 | 2018 | 19 | |
| 8 | 2021 | 16 | |
| 9 | 2020 | 15 | |
| 10 | 2022 | 13 | |
| 11 | 2023 | 5 | |
| 12 | 2022 | 4 | |
| 13 | 2016 | 3 | |
| 14 | 2019 | 2 | |
| 15 | 2017 | 1 |
About Edwin A. Basak
Edwin A. Basak is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 15 papers that have together received 454 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (15 papers), Biosimilars and Bioanalytical Methods (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Oncology (339 citations), Immunology (42 citations), Pulmonary and Respiratory Medicine (41 citations), Pharmacology (12 citations) and Endocrinology, Diabetes and Metabolism (17 citations). Edwin A. Basak has collaborated with scholars based in Netherlands and Switzerland. Frequent co-authors include Stijn L.W. Koolen, Ron H.J. Mathijssen, Joachim G.J.V. Aerts, Astrid Aplonia Maria van der Veldt, Sander Bins, Reno Debets, Esther Oomen‐de Hoop, Daan P. Hurkmans, Marco W.J. Schreurs and Stefan Sleijfer. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Annals of Oncology, European Journal of Cancer, Thyroid and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.